<DOC>
	<DOCNO>NCT00104026</DOCNO>
	<brief_summary>This study examine common feature gingival overgrowth ( excessive growth gum around teeth ) develop patient hereditary form condition develop condition side effect medication . A good understanding gingival overgrowth may help scientist develop medication few oral side effect . Patients age hereditary gingival fibromatosis blood relative , patient age gingival overgrowth take medication associate development disorder , include phenytoin ( diphenylhydantoin Dilantin ) , cyclosporine , calcium-channel blocker , may eligible study . Participants undergo medical dental history , include history medication use ; detail examination teeth , periodontium , head , neck ; photograph teeth gingival overgrowth ; dental x-ray ; blood test . DNA extract blood sample look gene relate gingival overgrowth . Patients gingival overgrowth offer two option , follow : - Tissue biopsy : A tissue sample take affected site , maximum three biopsy . For procedure , lidocaine first inject gum numb tissue . Then , cookie-cutter instrument push numbed skin , small piece tissue remove . - Gingivectomy : Surgical removal overgrown gingival .</brief_summary>
	<brief_title>Genes Associated With Hereditary Drug-Induced Gingival Overgrowth</brief_title>
	<detailed_description>The purpose protocol twofold : 1 ) continue identification gene associate hereditary gingival fibromatosis ( HGF ) , type gingival overgrowth 2 ) investigate gene up-regulated medication induce gingival overgrowth . These study establish common mechanism involve hereditary drug-induced process . If common pathway identify , could lead development assay could use screen new medication potential deleterious effect periodontal tissue . In addition , understand mechanism involve gingival overgrowth could lead development tissue engineering approach repair gingival defect . Genes identify DNA sample collect patient hereditary gingival fibromatosis . These compare DNA tissue sample take patient take medication know induce gingival overgrowth ( phenytoin , cyclosporine calcium channel blocker ) .</detailed_description>
	<mesh_term>Gingival Overgrowth</mesh_term>
	<mesh_term>Gingival Hyperplasia</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients age , gender , racial/ethnic group hereditary gingival fibromatosis ( HFG ) diagnose HGF clinical appearance consist attached gingival cover low 1/3 clinical crown teeth individual taking medication associate gingival change . Blood relative affect individual risk inherit HGF . Patients age , gender , racial/ethnic group take one three medication associate druginduced gingival overgrowth ( phenytoin diphenylhydantoin Dilantin , cyclosporine , calciumchannel blocker ) . Patients six teeth . EXCLUSION CRITERIA : Patients significant cognitive impairment . Pregnant patient lactate patient . Patients unwilling give inform consent . Patients less six teeth .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 19, 2011</verification_date>
	<keyword>Periodontal Disease</keyword>
	<keyword>Dilantin</keyword>
	<keyword>Cyclosporin</keyword>
	<keyword>Calcium-Channel Blockers</keyword>
	<keyword>Genetics</keyword>
	<keyword>Hereditary Gingival Fibromatosis</keyword>
	<keyword>HGF</keyword>
	<keyword>Gingival Overgrowth</keyword>
	<keyword>Gum Overgrowth</keyword>
</DOC>